Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Pfizer, BioNTech COVID vaccine gets EU regulatory nod, inoculation to start from Dec 27

Ruchika Sharma22 Dec 2020 2:00 PM IST

Amsterdam: Europe's medicines regulator on Monday approved the use of the Covid-19 vaccine developed by U.S. company Pfizer and its German partner...

Dr Reddys, Russia together to produce Sputnik V vaccine for COVID-19: Russian envoy

Ruchika Sharma22 Dec 2020 11:32 AM IST

Sputnik V vaccine has shown 92 percent efficacy in preventing COVID-19, according to the interim trial results announced by the country's health...

Lupin secures USFDA nod for Rufinamide Oral Suspension

Ruchika Sharma22 Dec 2020 11:20 AM IST

Mumbai, Baltimore: Pharma major, Lupin Limited, has recently announced that the company has received approval for its Rufinamide Oral Suspension,...

China signals Genetically Modified, biotech push in key policy statement: Report

Ruchika Sharma22 Dec 2020 9:00 AM IST

Shanghai/Beijing: China will industrialise biotech breeding as part of a campaign to improve food security, top leaders said in a policy statement...

Takeda Pharma Chief asks transparency in virus vaccine rollout

Ruchika Sharma21 Dec 2020 1:52 PM IST

Tokyo: Pharmaceutical firms must be "very transparent" about the risks and benefits of vaccines in efforts to end the coronavirus pandemic, the head...

Adar Poonawalla says govt need to indemnify vaccine makers against all lawsuits

Ruchika Sharma21 Dec 2020 1:29 PM IST

New Delhi: Vaccine manufacturers need to have protection against all lawsuits for their vaccines especially during a pandemic, Serum Institute of...

Mylan Wins Summary Judgment against Sanofi in EpiPen Litigation

Ruchika Sharma21 Dec 2020 1:26 PM IST

"Viatris is extremely pleased with this significant action by the Court as it rejects Sanofi Inc's baseless attempts to argue that Mylan used...

Novartis intrathecal onasemnogene abeparvovec Phase III study

Novartis inclisiran gets complete USFDA response letter for treating hyperlipidemia

Ruchika Sharma21 Dec 2020 1:01 PM IST

The FDA stated that the agency cannot approve the NDA by the Prescription Drug User Fee Act(PDUFA) action date of December 23, 2020, due to unresolved...

Glenmark Pharma gets USFDA nod for Dabigatran Etexilate Capsules

Ruchika Sharma21 Dec 2020 12:39 PM IST

Mumbai: Drugmaker, Glenmark Pharmaceuticals Ltd, today announced that the company has received tentative approval by the United States Food &...

Huge potential for medical technology sector in India: S Aparna

Ruchika Sharma20 Dec 2020 10:00 AM IST

New Delhi: The medical technology field is recognised as a sunrise sector in India and has huge potential for growth in the country, Department of...

JnJ enrolls about 45,000 participants for COVID vaccine late-stage trial

Ruchika Sharma20 Dec 2020 9:15 AM IST

J&J said it plans to submit an emergency use authorization application to the USFDA in February if the data from the study is safe and effective.

Pfizer applies for Japenese approval for COVID vaccine

Ruchika Sharma20 Dec 2020 9:00 AM IST

Tokyo: Drugmaker Pfizer Inc said on Friday it had applied for approval in Japan for its COVID-19 vaccine, which is already being administered in the...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok